These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31145100)

  • 21. The genomic and transcriptomic landscape of metastastic urothelial cancer.
    Loriot Y; Kamal M; Syx L; Nicolle R; Dupain C; Menssouri N; Duquesne I; Lavaud P; Nicotra C; Ngocamus M; Lacroix L; Tselikas L; Crehange G; Friboulet L; Castel-Ajgal Z; Neuzillet Y; Borcoman E; Beuzeboc P; Marret G; Gutman T; Wong J; Radvanyi F; Dureau S; Scoazec JY; Servant N; Allory Y; Besse B; Andre F; Le Tourneau C; Massard C; Bieche I
    Nat Commun; 2024 Oct; 15(1):8603. PubMed ID: 39366934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological Features of FGFR3 - Mutated Upper Tract Urothelial Carcinoma: A Genomic Database Analysis.
    Rizzo A; Mollica V; Santoni M; Massari F
    Clin Genitourin Cancer; 2022 Oct; 20(5):482-487. PubMed ID: 35858936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling.
    Robinson BD; Vlachostergios PJ; Bhinder B; Liu W; Li K; Moss TJ; Bareja R; Park K; Tavassoli P; Cyrta J; Tagawa ST; Nanus DM; Beltran H; Molina AM; Khani F; Miguel Mosquera J; Xylinas E; Shariat SF; Scherr DS; Rubin MA; Lerner SP; Matin SF; Elemento O; Faltas BM
    Nat Commun; 2019 Jul; 10(1):2977. PubMed ID: 31278255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma.
    Izquierdo L; Ingelmo-Torres M; Mallofré C; Lozano JJ; Verhasselt-Crinquette M; Leroy X; Colin P; Comperat E; Roupret M; Alcaraz A; Mengual L
    BJU Int; 2014 May; 113(5):813-21. PubMed ID: 24180461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma.
    Wu S; Chen J; Dong P; Zhang S; He Y; Sun L; Zhu J; Cheng Y; Li X; Tang A; Huang Y; Gui Y; Liu C; Yang G; Zhou F; Cai Z; Wang R
    BMC Cancer; 2014 Nov; 14():836. PubMed ID: 25408144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples.
    Pierconti F; Martini M; Fiorentino V; Cenci T; Racioppi M; Foschi N; Di Gianfrancesco L; Sacco E; Rossi E; Larocca LM; Bassi PF
    Hum Pathol; 2021 Dec; 118():42-48. PubMed ID: 34582934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant Association of Cyclo-oxygenase 2 Genotypes with Upper Tract Urothelial Cancer.
    Chang WS; Liao CH; Hsu CM; Huang CY; Fang HY; Kao PY; Tsai CW; Wu HC; Hu PS; Wang TC; Syu YR; Shui HA; Bau DT
    Anticancer Res; 2015 May; 35(5):2725-30. PubMed ID: 25964551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Implications of the Molecular and Genomic Landscape of Upper Tract Urothelial Carcinoma.
    Jaime-Casas S; Tripathi A; Pal SK; Yip W
    Curr Urol Rep; 2024 Oct; 26(1):11. PubMed ID: 39379745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
    Li WM; Huang CN; Ke HL; Li CC; Wei YC; Yeh HC; Chang LL; Huang CH; Liang PI; Yeh BW; Chan TC; Li CF; Wu WJ
    Oncotarget; 2016 Nov; 7(47):77777-77792. PubMed ID: 27780919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Methylation status of RASSF1A gene promoter in upper tract urothelial carcinoma and its clinical significance].
    Liu J; Xiong GY; Tang Q; Fang D; Li XS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):571-578. PubMed ID: 29263491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inherited mutations in Chinese patients with upper tract urothelial carcinoma.
    Wu J; Jin S; Gu C; Wei Y; Zhu Y; Necchi A; Shariat SF; Pan J; Gan H; Dai B; Zhang H; Shi G; Zhu Y; Shen Y; Zhu Y; Ye D
    Cell Rep Med; 2023 Jan; 4(1):100883. PubMed ID: 36630951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma.
    Deuker M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
    Clin Genitourin Cancer; 2021 Apr; 19(2):117-124. PubMed ID: 33358490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current Knowledge on Genomic Profiling of Upper Tract Urothelial Carcinoma.
    De Lorenzis E; Albo G; Longo F; Bebi C; Boeri L; Montanari E
    Genes (Basel); 2021 Feb; 12(3):. PubMed ID: 33668859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic profile - a possible diagnostic and prognostic marker in upper tract urothelial carcinoma.
    Grahn A; Eisfeldt J; Malm C; Foroughi Asl H; Jaremko G; Tham E; Brehmer M
    BJU Int; 2022 Jul; 130(1):92-101. PubMed ID: 34375486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.
    Hoang ML; Chen CH; Sidorenko VS; He J; Dickman KG; Yun BH; Moriya M; Niknafs N; Douville C; Karchin R; Turesky RJ; Pu YS; Vogelstein B; Papadopoulos N; Grollman AP; Kinzler KW; Rosenquist TA
    Sci Transl Med; 2013 Aug; 5(197):197ra102. PubMed ID: 23926200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility and tissue concordance of genomic sequencing of urinary cytology in upper tract urothelial carcinoma.
    Katims AB; Gaffney C; Firouzi S; Yip W; Aulitzky A; Pietzak EJ; Donat SM; Bochner BH; Donahue TF; Herr HW; Dalbagni G; Al-Ahmadie H; Kim K; Solit DB; Lin O; Coleman JA
    Urol Oncol; 2023 Oct; 41(10):433.e19-433.e24. PubMed ID: 37640571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation.
    Zhang L; Xiong G; Fang D; Li X; Liu J; Ci W; Zhao W; Singla N; He Z; Zhou L
    J Exp Clin Cancer Res; 2015 Jan; 34(1):5. PubMed ID: 25613404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Programmed Death-ligand 1 Expression in Upper Tract Urothelial Carcinoma.
    Skala SL; Liu TY; Udager AM; Weizer AZ; Montgomery JS; Palapattu GS; Siddiqui J; Cao X; Fields K; Abugharib AE; Soliman M; Hafez KS; Miller D; Lee CT; Alva A; Chinnaiyan AM; Morgan TM; Spratt DE; Jiang H; Mehra R
    Eur Urol Focus; 2017 Oct; 3(4-5):502-509. PubMed ID: 28753826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma.
    Nakano K; Koh Y; Yamamichi G; Yumiba S; Tomiyama E; Matsushita M; Hayashi Y; Wang C; Ishizuya Y; Yamamoto Y; Kato T; Hatano K; Kawashima A; Ujike T; Fujita K; Kiyotani K; Katayama K; Yamaguchi R; Imoto S; Imamura R; Nonomura N; Uemura M
    Cancer Sci; 2022 May; 113(5):1830-1842. PubMed ID: 35293110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
    Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.